Pfizer Settlement Means New Oversight; Does It Mean A New Marketing Plan?
The government may be hoping the third time's the charm as it enters into a new corporate integrity agreement with Pfizer
You may also be interested in...
Appeals court rules that aggregate data of government expenditures are not a substitute evidence of actual false claims and that FCA does protect whistleblowers who just report regulatory violations.
Pfizer, which co-markets the Alzheimer's treatment with Eisai, could feel the biggest impact of the notice of violation due to its settlement with state attorneys general.
Lessons From The Pfizer Off-Label Settlement: Compliance Programs Not Enough To Demonstrate Integrity, DOJ Says
A lesson of Pfizer's $2.3 billion corporate integrity settlement with the Department of Justice is that good integrity policies are meaningless without employee adherence, according to government attorneys